Literature DB >> 10749559

Replication-selective microbiological agents: fighting cancer with targeted germ warfare.

D H Kirn1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10749559      PMCID： PMC377493          DOI： 10.1172/JCI9761

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  Studies on the use of viruses in the treatment of carcinoma of the cervix.

Authors:  R J HUEBNER; W P ROWE; W E SCHATTEN; R R SMITH; L B THOMAS
Journal:  Cancer       Date:  1956 Nov-Dec       Impact factor: 6.860

2.  The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.

Authors:  W B Coley
Journal:  Clin Orthop Relat Res       Date:  1991-01       Impact factor: 4.176

3.  ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents.

Authors:  C Heise; A Sampson-Johannes; A Williams; F McCormick; D D Von Hoff; D H Kirn
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

4.  Treatment of human cancer with mumps virus.

Authors:  T Asada
Journal:  Cancer       Date:  1974-12       Impact factor: 6.860

5.  Viruses in the treatment of cancer.

Authors:  H E Webb; C E Smith
Journal:  Lancet       Date:  1970-06-06       Impact factor: 79.321

6.  Tumor-targeted Salmonella as a novel anticancer vector.

Authors:  J M Pawelek; K B Low; D Bermudes
Journal:  Cancer Res       Date:  1997-10-15       Impact factor: 12.701

7.  Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.

Authors:  A Morales; D Eidinger; A W Bruce
Journal:  J Urol       Date:  1976-08       Impact factor: 7.450

8.  Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.

Authors:  T Mineta; S D Rabkin; T Yazaki; W D Hunter; R L Martuza
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

Review 9.  In situ cytokine gene transfection using vaccinia virus vectors.

Authors:  E C Lattime; S S Lee; L C Eisenlohr; M J Mastrangelo
Journal:  Semin Oncol       Date:  1996-02       Impact factor: 4.929
  9 in total
  8 in total

1.  Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

Authors:  T Todo; R L Martuza; S D Rabkin; P A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Vesicular stomatitis virus induces apoptosis in the Wong-Kilbourne derivative of the Chang conjunctival cell line.

Authors:  Eva Gallyas; György Seprényi; Eniko Sonkoly; Yvette Mándi; Lajos Kemény; Klára Megyeri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-11-19       Impact factor: 3.117

3.  Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells.

Authors:  S Taneja; J MacGregor; S Markus; S Ha; I Mohr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium.

Authors:  Steven A Rosenberg; Paul J Spiess; David E Kleiner
Journal:  J Immunother       Date:  2002 May-Jun       Impact factor: 4.456

5.  Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.

Authors:  Hideo Nakamura; Hideki Kasuya; John T Mullen; Sam S Yoon; Timothy M Pawlik; Soundararajalu Chandrasekhar; James M Donahue; E Antonio Chiocca; Richard Y Chung; Kenneth K Tanabe
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer.

Authors:  Tohru Yamada; Masatoshi Goto; Vasu Punj; Olga Zaborina; Mei Ling Chen; Kazuhide Kimbara; Dibyen Majumdar; Elizabeth Cunningham; Tapas K Das Gupta; Ananda M Chakrabarty
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-22       Impact factor: 11.205

Review 7.  Endoscopic ultrasound-guided therapies in pancreatic neoplasms.

Authors:  Dennis Yang; Christopher J DiMaio
Journal:  Biomed Res Int       Date:  2015-01-31       Impact factor: 3.411

8.  Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.

Authors:  T Reid; E Galanis; J Abbruzzese; D Sze; J Andrews; L Romel; M Hatfield; J Rubin; D Kirn
Journal:  Gene Ther       Date:  2001-11       Impact factor: 5.250
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.